Julie Forman-Kay is program head in molecular medicine at the Hospital for Sick Children in Toronto, Canada. She received her B.Sc. in chemistry from the Massachusetts Institute of Technology and her Ph.D. in molecular biophysics andd biochemistry from Yale University. The major focus of her lab is to provide biological insights into how dynamic properties of proteins are related to function and methodological tools to enable better understanding of dynamic and disordered states. Most recently, her lab has probed the biophysics of protein phase separation and how it regulates cellular condensates and biological function.
Julie Forman-Kay
Program head
Hospital for Sick Children
From this contributor
How microscopic ‘condensates’ in cells might contribute to autism
A controversial idea about how cells compartmentalize their contents into droplets — like beads of oil in water — could be key to understanding autism, says Julie Forman-Kay.
How microscopic ‘condensates’ in cells might contribute to autism
By
Angie Voyles Askham
23 February 2021 | 7 min read
Explore more from The Transmitter
Dimensionality—neuroscience’s red herring?
Placing too much emphasis on a specific interpretation of dimensionality, or treating it as an end-all quantification of some aspect of neural computation, may hinder progress in understanding the brain.
Dimensionality—neuroscience’s red herring?
Placing too much emphasis on a specific interpretation of dimensionality, or treating it as an end-all quantification of some aspect of neural computation, may hinder progress in understanding the brain.
By
Matthew Perich
7 September 2026 | 8 min read
Dutch primate center awaits October animal research debate
Science is forging ahead at the Biomedical Primate Research Centre in the Netherlands, following a reversal of last year’s mandate to phase out primate studies. But researchers aren’t sure how long the reprieve will last.
Dutch primate center awaits October animal research debate
Science is forging ahead at the Biomedical Primate Research Centre in the Netherlands, following a reversal of last year’s mandate to phase out primate studies. But researchers aren’t sure how long the reprieve will last.
By
Lauren Schenkman
2 September 2026 | 5 min read
When we sleep, our brain is filled with spontaneous neural activity. What is it doing?
Daniel Levenstein explains how internally generated brain activity during sleep shapes our cognition, and why NeuroAI is such a powerful approach to understanding the brain.
When we sleep, our brain is filled with spontaneous neural activity. What is it doing?
Daniel Levenstein explains how internally generated brain activity during sleep shapes our cognition, and why NeuroAI is such a powerful approach to understanding the brain.
By
Paul Middlebrooks
2 September 2026 | 96 min listen